Antimicrobial Resistance: Threat, consequences and options
10 April 2019
Antimicrobial therapy is the mainstay of the three biggest public health programmes— HIV, tuberculosis and malaria. In tuberculosis and malaria, drug resistance has already emerged as a critical issue that is seriously threatening to undo the achievements made by the global community, even after investments of billions of dollars of national and international resources.
Further reading: The National Medical Journal of India
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
